3,022
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Drug interactions detected by a computer-assisted prescription system in primary care patients in Spain: MULTIPAP study

ORCID Icon, ORCID Icon, ORCID Icon, , , , , ORCID Icon & show all
Pages 90-96 | Received 10 Oct 2020, Accepted 06 Apr 2021, Published online: 13 May 2021

References

  • Ministerio de Sanidad y Consumo. Estudio APEAS. Estudio sobre la seguridad de los pacientes en atención primaria de salud. Madrid Minist. Sanid. y Consum. Madrid: Ministerio de Sanidad y Consumo; 2008.
  • Guthrie B, Makubate B, Hernandez-Santiago V, et al. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC Med. 2015;13(1):74.
  • Lopez-Picazo JJ, Ruiz JC, Sanchez JF, et al. Prevalence and typology of potential drug interactions occurring in primary care patients. Eur J Gen Pract. 2010;16(2):92–99.
  • Galindo-Ocaña J, Gil-Navarro MV, García-Morillo JS, et al. Drug-drug interactions in a multicentre polypathological polymedicated patients. Rev Clin Esp. 2010;210(6):270–278.
  • Zheng WY, Richardson LC, Li L, et al. Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2018;74(1):15–27.
  • Weingart SN, Simchowitz B, Shiman L, et al. Clinicians’ assessments of electronic medication safety alerts in ambulatory care. Arch Intern Med. 2009;169(17):1627–1632.
  • González-Rojano E, Acosta SV, Palacián DR, et al. Utility of checkthemeds® for detection of potentially inappropriate medication in hospitalized patients. Clin Ther. 2017;39(8):e37.
  • Prados-Torres A, Cura-González I, Prados-Torres D, et al. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project). Implement Sci. 2017;12:1–10. Article number: 54.
  • Doubova SV, Reyes-Morales H, Torres-Arreola LDP, et al. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res. 2007;7(1):1–8.
  • Lopez-Rodriguez JA, Rogero-Blanco E, Aza-Pascual-Salcedo M, et al. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: a cross-sectional study. PLoS One. 2020;15(8):e0237186.
  • Gören ZJ, Demirkapu M, Akpinar Acet G, et al. Potential drug-drug interactions among prescriptionsfor elderly patients in primary health care. Turk J Med Sci. 2017;47:47–54.
  • Aljadani R, Aseeri M. Prevalence of drug-drug interactions in geriatric patients at an ambulatory care pharmacy in a tertiary care teaching hospital. BMC Res Notes. 2018;11(1):234.
  • Nikolic B, Jankovic S, Stojanov O, et al. Prevalence and predictors of potential drug-drug interactions. Cent Eur J Med. 2014;9(2):348–356.
  • Sánchez-Fidalgo S, Guzmán-Ramos MI, Galván-Banqueri M, et al. Prevalence of drug interactions in elderly patients with multimorbidity in primary care. Int J Clin Pharm. 2017;39(2):343–353.